Search
Patexia Research
Case number 1:17-cv-01047

Bayer Intellectual Property GmbH et al v. Lupin Limited et al > Documents

Date Field Doc. No.Description (Pages)
Dec 30, 2020 42 Order (2)
Dec 30, 2020 42 Main Document (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218. (Attachments: # (1) Order)(nms)
Dec 22, 2020 N/A Terminated Case (0)
Docket Text: CASE CLOSED per entry of D.I. 230 in Lead Civil Action 17-462-TBD. (nms)
Dec 21, 2020 41 Letter (1)
Docket Text: Letter to The Honorable Richard G. Andrews from Jack B. Blumenfeld regarding closure of underlying cases. (Blumenfeld, Jack)
Dec 21, 2020 N/A Oral Order (0)
Docket Text: ORAL ORDER: The parties shall file a status letter within 7 days of the date of this Order. Ordered by Judge Richard G. Andrews on 12/21/2020. (nms)
Jul 8, 2020 1 Complaint (11)
Oct 9, 2018 39 Order Administratively Closing Case (1)
Docket Text: ORDER: The case is ADMINISTRATIVELY CLOSED. The parties shall promptly notify the Court when the related litigation has been resolved so this case may be reopened and other appropriate action may be taken. Signed by Judge Richard G. Andrews on 10/9/2018. (nms)
Jul 24, 2018 38 Notice (Other) (2)
Docket Text: NOTICE of Withdrawal of Pro Hac Vice Counsel Holly Hawkins Saporito by Lupin Limited, Lupin Pharmaceuticals, Inc. (Lennon, James)
Jul 24, 2018 37 Motion for Leave to Appear Pro Hac Vice (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher B. Ferenc - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Lennon, James)
Jul 24, 2018 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [37] MOTION for Pro Hac Vice Appearance of Attorney Christopher B. Ferenc, filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 7/24/2018. (nms)
May 1, 2018 N/A SO ORDERED (0)
Apr 30, 2018 36 Motion for Leave to Appear Pro Hac Vice (5)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Lance Sodertrom, Deepro R. Mukerjee, and Joseph M. Janusz - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Lennon, James)
Apr 30, 2018 35 Notice (Other) (3)
Docket Text: NOTICE of Change of Firm Affiliation by Lupin Limited, Lupin Pharmaceuticals, Inc. (Lennon, James)
Nov 13, 2017 N/A SO ORDERED (0)
Nov 13, 2017 34 Notice (Other) (2)
Docket Text: NOTICE of SERVICE of Defendants' core technical documents related to ANDA No. 208555 by Lupin Limited, Lupin Pharmaceuticals, Inc. (Lennon, James)
Nov 13, 2017 33 Order (7)
Docket Text: SO ORDERED Granting (26 in 17-cv-1163-RGA, 28 in 17-cv-462-RGA, 27 in 17-cv-584-RGA, 23 in 17-cv-675-RGA, 29 in 17-cv-648-RGA, 24 in 17-cv-560-RGA, 29 in 17-cv-1129-RGA, 26 in 17-cv-483-RGA, 25 in 17-cv-812-RGA, 32 in 17-cv-1047-RGA) Stipulation and Order of Consolidation. Signed by Judge Richard G. Andrews on 11/13/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms)
Nov 10, 2017 32 Stipulation (7)
Docket Text: STIPULATION and [Proposed] Order of Consolidation by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek)
Nov 9, 2017 31 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants' counterclaims to November 27, 2017 - filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 11/9/2017 (nms).
Oct 24, 2017 30 Order (30)
Docket Text: SO ORDERED Granting Stipulated Protective Order. Signed by Judge Richard G. Andrews on 10/24/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms)
Oct 24, 2017 N/A SO ORDERED (0)
Oct 23, 2017 29 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to counterclaims to November 9, 2017 - filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/24/2017 (nms).
Oct 23, 2017 28 Proposed Order (30)
Docket Text: PROPOSED Protective Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/23/2017 (nms).
Oct 23, 2017 N/A SO ORDERED (0)
Oct 20, 2017 27 Stipulation (6)
Docket Text: STIPULATION and Order on Proposed Protective Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/23/2017 (nms).
Oct 17, 2017 26 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Rule 27(a)(1) Initial Disclosures filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James)
Oct 17, 2017 N/A SO ORDERED (0)
Oct 16, 2017 25 Motion for Leave to Appear Pro Hac Vice (13)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Todd L. Krause of Sidley Austin LLP - filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek)
Oct 13, 2017 24 Notice of Service (14)
Docket Text: NOTICE OF SERVICE of (1) Bayer Intellectual Property GmbH and Bayer AG's Initial Disclosures; and (2) Janssen Pharmaceuticals, Inc.'s Initial Disclosures filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
Oct 12, 2017 23 Notice (Other) (2)
Docket Text: NOTICE of SERVICE of Lupin Limited And Lupin Pharmaceuticals, Inc.s Initial Disclosures Pursuant To Paragraph 3 of the Default Standard for Discovery by Lupin Limited, Lupin Pharmaceuticals, Inc. (Lennon, James)
Oct 12, 2017 N/A SO ORDERED (0)
Oct 11, 2017 21 Notice of Service (14)
Docket Text: NOTICE OF SERVICE of Plaintiffs Bayer Intellectual Property GmbH, Bayer AG, and Janssen Pharmaceuticals, Inc.'s Initial Identification of Asserted Patents and Accused Products filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek)
Oct 11, 2017 22 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to answer, move, or otherwise respond to Defendants' counterclaims to October 26, 2017 - filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/12/2017 (nms).
Oct 2, 2017 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-00462-RGA et al.(cak)
Oct 2, 2017 20 Scheduling Order (11)
Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/9/2018. Amended Pleadings due by 3/9/2018. Fact Discovery completed by 8/10/2018. Joint Claim Construction Brief due by 6/22/2018. A Markman Hearing is set for 7/3/2018, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A Pretrial Conference is set for 3/22/2019, at 9:00 AM in Courtroom 6A before Judge Richard G. Andrews. A 3 day Bench Trial is set for 4/1/2019, at 9:30 AM in Courtroom 6A before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/29/2017. Associated Cases: 1:17-cv-00462-RGA et al.(nms)
Sep 29, 2017 19 Letter (1)
Sep 29, 2017 19 Proposed Order (11)
Sep 29, 2017 19 Main Document (11)
Docket Text: PROPOSED Scheduling Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Letter)(Smith, Rodger) Modified on 9/29/2017 (nms).
Sep 20, 2017 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Stephanie M. Roberts for Lupin Limited,Stephanie M. Roberts for Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
Sep 20, 2017 N/A Add Attorneys Pro Hac Vice (0)
Sep 20, 2017 N/A SO ORDERED (0)
Sep 20, 2017 18 Motion for Leave to Appear Pro Hac Vice (3)
Docket Text: Amended MOTION for Pro Hac Vice Appearance of Attorney Stephanie M. Roberts - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Lennon, James) Modified on 9/20/2017 (nms).
Sep 14, 2017 17 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Holly Hawkins Saporito and Stephanie M. Robert - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Lennon, James)
Sep 14, 2017 N/A SO ORDERED (0)
Sep 11, 2017 N/A Scheduling Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 9/11/2017. (Court Reporter Valerie Gunning.) Associated Cases: 1:17-cv-00462-RGA et al.(ksr, )
Sep 11, 2017 N/A SO ORDERED (0)
Sep 8, 2017 16 Notice (Other) (3)
Docket Text: NOTICE of Change of Firm Affiliation by Lupin Limited, Lupin Pharmaceuticals, Inc. (Lennon, James)
Sep 8, 2017 15 Motion for Leave to Appear Pro Hac Vice (16)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Adam L. Perlman, Dov P. Grossman, Alexander S. Zolan, Martha C. Kidd and Kathryn S. Kayali - filed by Bayer AG, Bayer Intellectual Property GmbH. (Smith, Rodger)
Sep 8, 2017 14 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to answer, move, or otherwise respond to Defendants' counterclaims to October 12, 2017 - filed by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Smith, Rodger)
Sep 8, 2017 N/A SO ORDERED (0)
Sep 7, 2017 13 Proposed Order (11)
Docket Text: PROPOSED Scheduling Order, by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 9/7/2017 (nms).
Sep 1, 2017 12 Order Setting Scheduling Conference (1)
Docket Text: Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 9/11/2017, at 11:00 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/1/2017. (nms)
Aug 22, 2017 11 Disclosure Statement (4)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited, Other Affiliate Lupin Inc. for Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Lennon, James)
Aug 22, 2017 10 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,415,053 B2; . (Lennon, James)
Aug 22, 2017 9 Exhibit 1 (12)
Aug 22, 2017 9 Answer to Complaint (32)
Aug 22, 2017 9 Main Document (32)
Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIM against Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc. by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit 1)(Lennon, James) Modified on 8/22/2017 (nms).
Aug 2, 2017 8 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer AG. Lupin Pharmaceuticals, Inc. served on 8/1/2017, answer due 8/22/2017. (Blumenfeld, Jack)
Aug 2, 2017 7 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer AG. Lupin Limited served on 8/1/2017, answer due 8/22/2017. (Blumenfeld, Jack)
Aug 2, 2017 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
Jul 28, 2017 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Lupin Limited on 7/31/2017; Lupin Pharmaceuticals, Inc. on 7/31/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg)
Jul 28, 2017 1 Main Document (11)
Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2192279.) - filed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer AG. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(nmg)
Jul 28, 2017 6 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc. (nmg)
Jul 28, 2017 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GmbH filed by Bayer AG, Bayer Intellectual Property GmbH. (nmg)
Jul 28, 2017 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2. (nmg)
Jul 28, 2017 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/14/2017. Date of Expiration of Patent: 2/17/2034.Thirty Month Stay Deadline: 12/14/2019. (nmg)
Jul 28, 2017 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg)
Jul 28, 2017 1 Civil Cover Sheet (1)
Jul 28, 2017 1 Exhibit A (14)
Jul 28, 2017 1 Complaint* (1)
Menu